Cargando…
Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
BACKGROUND: This pilot study assesses the ability of plasma collected from Canadian blood donors in the first wave of the SARS‐CoV‐2 pandemic to neutralize later SARS‐CoV‐2 variants of concern (VOCs). STUDY DESIGN AND METHODS: A repeated cross‐sectional design was used, and a random cross‐sectional...
Autores principales: | Drews, Steven J., Abe, Kento T., Hu, Queenie, Samson, Reuben, Gingras, Anne‐Claude, Colwill, Karen, Rathod, Bhavisha, Wang, Jenny, Fazel‐Zarandi, Mahya, Yi, Qi‐Long, Robinson, Alyssia, Wood, Heidi, Tuite, Ashleigh, Fisman, David, Evans, David H., Lin, Yi‐Chan J., O'Brien, Sheila F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662190/ https://www.ncbi.nlm.nih.gov/pubmed/34662434 http://dx.doi.org/10.1111/trf.16713 |
Ejemplares similares
-
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
por: Saeed, Sahar, et al.
Publicado: (2021) -
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
por: Tuite, Ashleigh R., et al.
Publicado: (2022) -
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022) -
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses
por: Lin, Yi-Chan J., et al.
Publicado: (2022) -
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
por: Abe, Kento T., et al.
Publicado: (2022)